A series of novel 4-aminoquinoline-purine hybrids was synthesized. Potent antiplasmodial activity against CQ-sensitive and CQ-resistant strains. Up to six-fold better activity than reference drug (CQ) against resistant strain. Mechanistic heme-binding studies showed 1:1 binding stoichiometry. Computational docking studies with HGPRT protein revealed good binding interactions.